The role of NOS2 in neurodegeneration has been studied in murine experimental models of MS utilising demyelination-inducing chemicals, peptides, or virus strains, the outcomes of which often depend on differential disease pathology and the role of infiltrating T cells. Here, NOS2 is linked to myeloid sarcoma.